DK1237915T3 - Polynucleotid, som kodet for polypeptidet RG1 - Google Patents
Polynucleotid, som kodet for polypeptidet RG1Info
- Publication number
- DK1237915T3 DK1237915T3 DK00990937T DK00990937T DK1237915T3 DK 1237915 T3 DK1237915 T3 DK 1237915T3 DK 00990937 T DK00990937 T DK 00990937T DK 00990937 T DK00990937 T DK 00990937T DK 1237915 T3 DK1237915 T3 DK 1237915T3
- Authority
- DK
- Denmark
- Prior art keywords
- polypeptides
- polynucleotide
- polypeptide
- encoded
- methods
- Prior art date
Links
- 229920001184 polypeptide Polymers 0.000 title abstract 6
- 102000004196 processed proteins & peptides Human genes 0.000 title abstract 6
- 108090000765 processed proteins & peptides Proteins 0.000 title abstract 6
- 102000040430 polynucleotide Human genes 0.000 title abstract 3
- 108091033319 polynucleotide Proteins 0.000 title abstract 3
- 239000002157 polynucleotide Substances 0.000 title abstract 3
- 238000000034 method Methods 0.000 abstract 2
- 102000010834 Extracellular Matrix Proteins Human genes 0.000 abstract 1
- 108010037362 Extracellular Matrix Proteins Proteins 0.000 abstract 1
- 210000004027 cell Anatomy 0.000 abstract 1
- 238000003745 diagnosis Methods 0.000 abstract 1
- 239000013604 expression vector Substances 0.000 abstract 1
- 210000002744 extracellular matrix Anatomy 0.000 abstract 1
- 230000001225 therapeutic effect Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/78—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin or cold insoluble globulin [CIG]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/08—Drugs for disorders of the urinary system of the prostate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/4748—Tumour specific antigens; Tumour rejection antigen precursors [TRAP], e.g. MAGE
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Gastroenterology & Hepatology (AREA)
- Zoology (AREA)
- Toxicology (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Oncology (AREA)
- Engineering & Computer Science (AREA)
- Urology & Nephrology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Saccharide Compounds (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US17237099P | 1999-12-16 | 1999-12-16 | |
US09/732,357 US6682902B2 (en) | 1999-12-16 | 2000-12-07 | DNA encoding a novel RG1 polypeptide |
PCT/US2000/033901 WO2001044291A2 (en) | 1999-12-16 | 2000-12-15 | Polynucleotid encoding the rg1 polypeptide |
Publications (1)
Publication Number | Publication Date |
---|---|
DK1237915T3 true DK1237915T3 (da) | 2009-11-16 |
Family
ID=26868022
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK00990937T DK1237915T3 (da) | 1999-12-16 | 2000-12-15 | Polynucleotid, som kodet for polypeptidet RG1 |
Country Status (32)
Country | Link |
---|---|
US (5) | US6682902B2 (xx) |
EP (2) | EP2048157B1 (xx) |
JP (1) | JP4979867B2 (xx) |
KR (1) | KR100752434B1 (xx) |
CN (1) | CN1297566C (xx) |
AT (1) | ATE440862T1 (xx) |
AU (1) | AU784674B2 (xx) |
BG (1) | BG65898B1 (xx) |
BR (1) | BR0017022A (xx) |
CA (1) | CA2394574A1 (xx) |
CZ (1) | CZ299232B6 (xx) |
DE (1) | DE60042836D1 (xx) |
DK (1) | DK1237915T3 (xx) |
EE (1) | EE05293B1 (xx) |
ES (1) | ES2331106T3 (xx) |
HR (1) | HRP20020549B1 (xx) |
HU (1) | HU229001B1 (xx) |
IL (2) | IL150115A0 (xx) |
LT (1) | LT5046B (xx) |
ME (1) | MEP37808A (xx) |
MX (1) | MXPA02005914A (xx) |
NO (1) | NO330924B1 (xx) |
NZ (1) | NZ519598A (xx) |
PL (1) | PL207634B1 (xx) |
PT (1) | PT1237915E (xx) |
RO (1) | RO122543B1 (xx) |
RS (1) | RS50831B (xx) |
RU (1) | RU2283130C2 (xx) |
SI (2) | SI1237915T1 (xx) |
SK (2) | SK288147B6 (xx) |
WO (1) | WO2001044291A2 (xx) |
ZA (1) | ZA200205638B (xx) |
Families Citing this family (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20020161199A1 (en) * | 1998-04-08 | 2002-10-31 | Genentech, Inc. | Compositions and methods for the diagnosis and treatment of tumor |
NZ528700A (en) * | 1998-04-08 | 2005-02-25 | Genentech Inc | Novel PRO866 polypeptides and nucleic acids with homology to mindin and spondin proteins |
US6960433B1 (en) | 1998-10-19 | 2005-11-01 | Diadexus, Inc. | Method of diagnosing, monitoring, staging, imaging and treating prostate cancer |
US20070031901A1 (en) * | 1999-03-08 | 2007-02-08 | Genentech, Inc. | Compositions and methods for the diagnosis and treatment of tumor |
US6682902B2 (en) * | 1999-12-16 | 2004-01-27 | Schering Aktiengesellschaft | DNA encoding a novel RG1 polypeptide |
EP1648510B1 (en) | 2003-07-22 | 2013-06-19 | Bayer Pharma Aktiengesellschaft | Rg1 antibodies and uses thereof |
US7294704B2 (en) | 2003-08-15 | 2007-11-13 | Diadexus, Inc. | Pro108 antibody compositions and methods of use and use of Pro108 to assess cancer risk |
US7785591B2 (en) | 2004-10-14 | 2010-08-31 | Morphosys Ag | Identification and characterization of function-blocking anti-ED-B-fibronectin antibodies |
TWI438207B (zh) * | 2007-02-21 | 2014-05-21 | Oncotherapy Science Inc | 表現腫瘤相關抗原之癌症的胜肽疫苗 |
EP2211908A2 (en) * | 2007-11-30 | 2010-08-04 | Bristol-Myers Squibb Company | Conjugates of anti-rg-1 antibodies |
TW201008574A (en) | 2008-08-19 | 2010-03-01 | Oncotherapy Science Inc | INHBB epitope peptides and vaccines containing the same |
CN102346184B (zh) * | 2010-08-03 | 2014-03-26 | 中国人民解放军军事医学科学院生物工程研究所 | Spon2的新用途 |
DE202012012998U1 (de) | 2011-08-31 | 2014-06-13 | Daniel Elias | Bioaktive, regenerative Mischung zur Herstellung eines Ergänzungsnahrungsmittels |
Family Cites Families (30)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4657760A (en) | 1979-03-20 | 1987-04-14 | Ortho Pharmaceutical Corporation | Methods and compositions using monoclonal antibody to human T cells |
US4683195A (en) | 1986-01-30 | 1987-07-28 | Cetus Corporation | Process for amplifying, detecting, and/or-cloning nucleic acid sequences |
US5206344A (en) | 1985-06-26 | 1993-04-27 | Cetus Oncology Corporation | Interleukin-2 muteins and polymer conjugation thereof |
US4946778A (en) | 1987-09-21 | 1990-08-07 | Genex Corporation | Single polypeptide chain binding molecules |
US5246692A (en) * | 1986-09-05 | 1993-09-21 | The United States Of America As Represented By The Secretary Of Health And Human Services | Backbone polysubstituted chelates for forming a metal chelate-protein conjugate |
US4831175A (en) * | 1986-09-05 | 1989-05-16 | The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services | Backbone polysubstituted chelates for forming a metal chelate-protein conjugate |
US4987071A (en) | 1986-12-03 | 1991-01-22 | University Patents, Inc. | RNA ribozyme polymerases, dephosphorylases, restriction endoribonucleases and methods |
US5437994A (en) | 1989-06-15 | 1995-08-01 | Regents Of The University Of Michigan | Method for the ex vivo replication of stem cells, for the optimization of hematopoietic progenitor cell cultures, and for increasing the metabolism, GM-CSF secretion and/or IL-6 secretion of human stromal cells |
US5399493A (en) | 1989-06-15 | 1995-03-21 | The Regents Of The University Of Michigan | Methods and compositions for the optimization of human hematopoietic progenitor cell cultures |
US5225212A (en) | 1989-10-20 | 1993-07-06 | Liposome Technology, Inc. | Microreservoir liposome composition and method |
US6150584A (en) * | 1990-01-12 | 2000-11-21 | Abgenix, Inc. | Human antibodies derived from immunized xenomice |
DE69127627T2 (de) | 1990-08-29 | 1998-02-19 | Genpharm Int | Produktion und Nützung nicht-menschliche transgentiere zur Produktion heterologe Antikörper |
US5877397A (en) | 1990-08-29 | 1999-03-02 | Genpharm International Inc. | Transgenic non-human animals capable of producing heterologous antibodies of various isotypes |
EP0641212A4 (en) | 1992-05-14 | 1997-05-21 | Ribozyme Pharm Inc | PROCESS AND REAGENT FOR PREVENTING THE DEVELOPMENT OF CANCER. |
US5871969A (en) | 1996-02-12 | 1999-02-16 | Human Genome Sciences, Inc. | Nucleic acids encoding human neuronal attachment factor-1 |
US6177244B1 (en) | 1996-05-10 | 2001-01-23 | Beth Israel Deaconess Medical Center Inc. | NPG-1 gene that is differentially expressed in prostate tumors |
US6287777B1 (en) | 1996-05-10 | 2001-09-11 | Beth Israel Deaconess Medical Center | NPG-1 gene that is differentially expressed in prostate tumors |
US5804382A (en) | 1996-05-10 | 1998-09-08 | Beth Israel Deaconess Medical Center, Inc. | Methods for identifying differentially expressed genes and differences between genomic nucleic acid sequences |
JP3494529B2 (ja) * | 1996-06-06 | 2004-02-09 | Ykk株式会社 | 一体成形面ファスナー |
EP0933994A4 (en) * | 1996-08-26 | 2002-09-18 | Univ Washington | THERAPEUTIC AND DIAGNOSTIC APPLICATIONS OF SPLICE VARIANTS OF THE PERLECAN I AREA |
AU6961398A (en) | 1997-04-10 | 1998-10-30 | Zymogenetics Inc. | Secreted f-spondin homologs |
CA2289116A1 (en) * | 1997-05-06 | 1998-11-12 | Human Genome Sciences, Inc. | Enterococcus faecalis polynucleotides and polypeptides |
WO1998050073A1 (en) | 1997-05-09 | 1998-11-12 | Smithkline Beecham Corporation | Integrin ligand, human mindin |
EP1490386B1 (en) | 1998-03-10 | 2008-08-13 | Genentech, Inc. | Novel polypeptide and nucleic acids encoding the same |
US6166176A (en) * | 1998-03-17 | 2000-12-26 | Immvarx, Inc. | Cancer marker protein and peptides thereof |
US6960433B1 (en) * | 1998-10-19 | 2005-11-01 | Diadexus, Inc. | Method of diagnosing, monitoring, staging, imaging and treating prostate cancer |
WO2000023108A1 (en) | 1998-10-19 | 2000-04-27 | Diadexus Llc | Method of diagnosing, monitoring, staging, imaging and treating prostate cancer |
EE05627B1 (et) * | 1998-12-23 | 2013-02-15 | Pfizer Inc. | CTLA-4 vastased inimese monoklonaalsed antikehad |
US6824780B1 (en) * | 1999-10-29 | 2004-11-30 | Genentech, Inc. | Anti-tumor antibody compositions and methods of use |
US6682902B2 (en) | 1999-12-16 | 2004-01-27 | Schering Aktiengesellschaft | DNA encoding a novel RG1 polypeptide |
-
2000
- 2000-12-07 US US09/732,357 patent/US6682902B2/en not_active Expired - Fee Related
- 2000-12-15 SK SK5055-2008A patent/SK288147B6/sk not_active IP Right Cessation
- 2000-12-15 JP JP2001544779A patent/JP4979867B2/ja not_active Expired - Fee Related
- 2000-12-15 PL PL356220A patent/PL207634B1/pl unknown
- 2000-12-15 DE DE60042836T patent/DE60042836D1/de not_active Expired - Lifetime
- 2000-12-15 KR KR1020027007708A patent/KR100752434B1/ko not_active IP Right Cessation
- 2000-12-15 SK SK848-2002A patent/SK286384B6/sk not_active IP Right Cessation
- 2000-12-15 RS YUP-446/02A patent/RS50831B/sr unknown
- 2000-12-15 NZ NZ519598A patent/NZ519598A/en not_active IP Right Cessation
- 2000-12-15 ME MEP-378/08A patent/MEP37808A/xx unknown
- 2000-12-15 SI SI200031038T patent/SI1237915T1/sl unknown
- 2000-12-15 CA CA002394574A patent/CA2394574A1/en not_active Abandoned
- 2000-12-15 AT AT00990937T patent/ATE440862T1/de active
- 2000-12-15 EP EP08163898A patent/EP2048157B1/en not_active Expired - Lifetime
- 2000-12-15 ES ES00990937T patent/ES2331106T3/es not_active Expired - Lifetime
- 2000-12-15 IL IL15011500A patent/IL150115A0/xx unknown
- 2000-12-15 BR BR0017022-4A patent/BR0017022A/pt not_active Application Discontinuation
- 2000-12-15 WO PCT/US2000/033901 patent/WO2001044291A2/en active Application Filing
- 2000-12-15 HU HU0204224A patent/HU229001B1/hu not_active IP Right Cessation
- 2000-12-15 RU RU2002119208/15A patent/RU2283130C2/ru not_active IP Right Cessation
- 2000-12-15 CZ CZ20022037A patent/CZ299232B6/cs not_active IP Right Cessation
- 2000-12-15 CN CNB008190518A patent/CN1297566C/zh not_active Expired - Fee Related
- 2000-12-15 EP EP00990937A patent/EP1237915B1/en not_active Expired - Lifetime
- 2000-12-15 AU AU30746/01A patent/AU784674B2/en not_active Ceased
- 2000-12-15 EE EEP200200323A patent/EE05293B1/xx not_active IP Right Cessation
- 2000-12-15 RO ROA200200857A patent/RO122543B1/ro unknown
- 2000-12-15 PT PT00990937T patent/PT1237915E/pt unknown
- 2000-12-15 DK DK00990937T patent/DK1237915T3/da active
- 2000-12-15 MX MXPA02005914A patent/MXPA02005914A/es active IP Right Grant
- 2000-12-15 SI SI200020058A patent/SI21140A/sl not_active IP Right Cessation
-
2002
- 2002-06-10 IL IL150115A patent/IL150115A/en not_active IP Right Cessation
- 2002-06-13 BG BG106823A patent/BG65898B1/bg unknown
- 2002-06-14 NO NO20022836A patent/NO330924B1/no not_active IP Right Cessation
- 2002-06-24 HR HRP20020549AA patent/HRP20020549B1/hr not_active IP Right Cessation
- 2002-06-24 LT LT2002070A patent/LT5046B/lt not_active IP Right Cessation
- 2002-07-15 ZA ZA200205638A patent/ZA200205638B/xx unknown
-
2003
- 2003-07-08 US US10/616,279 patent/US7307154B2/en not_active Expired - Fee Related
- 2003-07-22 US US10/624,884 patent/US20040152139A1/en not_active Abandoned
-
2007
- 2007-10-30 US US11/981,240 patent/US7887804B2/en not_active Expired - Fee Related
- 2007-10-30 US US11/981,132 patent/US7893217B2/en not_active Expired - Fee Related
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK1237915T3 (da) | Polynucleotid, som kodet for polypeptidet RG1 | |
ATE454403T1 (de) | Menschliche koagulationsfaktor vii polypeptide | |
ATE352626T1 (de) | Polypeptide mit galaktoseoxidaseaktivität und dafür kodierende nukleisäuren | |
WO2003080856A3 (en) | Therapeutic polypeptides, nucleic acids encoding same, and methods of use | |
BR9910396A (pt) | Polinucleotìdeo(s) e polipeptìdeos basb029 a partirde neisseria meningitidis | |
ATE424410T1 (de) | Interleukin-19. | |
DE60118359D1 (de) | Humanische pellino-polypeptide | |
WO2003029423A3 (en) | Therapeutic polypeptides, nucleic acids encoding same, and methods of use | |
WO2003031571A3 (en) | Novel human proteins, polynucleotides encoding them and methods of using the same | |
WO2003085124A8 (en) | Therapeutic polypeptides, nucleic acids encoding same, and methods of use | |
ATE554793T1 (de) | Konjugat | |
WO2002066506A3 (en) | Use of casb7439 (ash2) in the immunotherapy of breast cancer | |
ATE394420T1 (de) | Gen in zusammenhang mit haarausfall, das davon kodierte polypeptid und anwendungen dafür | |
WO2003052061A3 (en) | Novel human proteins, polynucleotides encoding them and methods of using the same | |
WO2003050245A8 (en) | Therapeutic polypeptides, nucleic acids encoding same, and methods of use | |
ATE454452T1 (de) | Basb118 polypeptid und polynukleotid aus moraxella catarrhalis | |
WO2003004617A3 (en) | Novel human proteins, polynucleotides encoding them and methods of using the same | |
WO2004022723A3 (en) | Therapeutic polypeptides, nucleic acids encoding same, and methods of use | |
WO2004015079A3 (en) | Therapeutic polypeptides, nucleic acids encoding same, and methods of use | |
ATE360073T1 (de) | Basb119 polypeptid und polynukleotid aus moraxella catarrhalis | |
WO2004055158A3 (en) | Therapeutic polypeptides, nucleic acids encoding same, and methods of use | |
WO2003040327A3 (en) | Novel human proteins, polynucleotides encoding them and methods of using the same | |
WO2003064629A3 (en) | Therapeutic polypeptides, nucleic acids encoding same, and methods of use | |
WO2001096526A3 (fr) | Nouveau polypeptide, facteur humain 11.77 d'inhibition tumorale, et polynucleotide codant ce polypeptide | |
WO2002098913A3 (en) | Polypeptides and corresponding polynucleotides for prophylaxis and treatment of colon cancer |